Hypertension in the elderly

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Gil Extremera, Blas ^a   Cía Gómez, Pedro ^b  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; ENALAPRIL MALEATE PLUS NITRENDIPINE; FELODIPINE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; LOSARTAN; NIFEDIPINE; NIMODIPINE; NITRENDIPINE; PERINDOPRIL; PLACEBO; PRAVASTATIN; VALSARTAN; VERAPAMIL;

ANGINA PECTORIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; DEMENTIA; DRUG EFFICACY; ELDERLY CARE; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; LIFE EXPECTANCY; MINI MENTAL STATE EXAMINATION; MORBIDITY; MORTALITY; NEUROPROTECTION; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 84868276994     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/859176     Document Type: Review

References (15)

1. Extremera B. G., Puertas J. A., Martín A. M., Factores de riesgo en ancianos. Estudio de 143 pacientes. Anales de Medicina Interna 1997 14 10 495 499 2-s2.0-0031243199
2. Staessen J. A., Fagard R., Thijs L., Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Lancet 1997 350 9080 757 764 10.1016/S0140-6736(97)05381-6 (Pubitemid 27387202)
3. Forette F., Seux M. L., Staessen J. A., Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (syst-eur) trial. The Lancet 1998 353 9137 1347 1351 2-s2.0-0032564132 10.1016/S0140-6736(98)03086-4 (Pubitemid 28510916)
4. Staessen J. A., Thijs L., Fagard R. H., Calcium channel blockade and cardiovascular prognosis in the european trial on isolated systolic hypertension. Journal of Hypertension 1998 32 3 410 416 2-s2.0-0031681305 (Pubitemid 28429127)
5. Thijs L., Richart T., De Leeuw P. W., Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the systolic hypertension in Europe trial. Journal of Hypertension 2010 28 4 865 874 2-s2.0-77952492993 10.1097/HJH.0b013e32833627c9
6. Forette F., Seux M. L., Staessen J. A., The prevention of dementia with antihypertensive treatment. Archives of Internal Medicine 2002 162 18 2046 2052 2-s2.0-0037078312 10.1001/archinte.162.18.2046 (Pubitemid 35168212)
7. Bulpitt C. J., Fletcher A. E., Beckett N., The hypertension in the very elderly trial (HYVET). Protocol for the main trial. Drugs and Aging 2001 18 3 151 164 2-s2.0-0035075847 (Pubitemid 32291390)
8. Bulpitt C. J., Beckett N. S., Cooke J., Dumitrascu D. L., Extremera B. G., Nachev C., Nunes M., Peters R., Staessen J. A., Thijs L., Results of the pilot study for the hypertension in the very elderly trial. Journal of Hypertension 2003 21 12 2401 2409 2-s2.0-10744233011
9. Bulpitt C. J., Beckett N. S., Cooke J., Results of the pilot study for the hypertension in the very elderly trial. Journal of Hypertension 2003 21 12 2409 2417 2-s2.0-10744233011 10.1097/00004872-200312000-00030 (Pubitemid 38293581)
10. Beckett N., Peters R., Fletcher A., Treatment of hypertension in patients 80 years of age or older. The New England Journal of Medicine 2008 358 18 1887 1898 (Pubitemid 351620109)
11. Black H. R., Elliott W. J., Neaton J. D., Baseline characteristics and early blood pressure control in the CONVINCE trial. Journal of Hypertension 2001 37 1 12 18 2-s2.0-0035148501 (Pubitemid 32064233)
12. Black H. R., Elliott W. J., Grandits G., Grambsch P., Lucente T., White W. B., Neaton J. D., Grimm Jr. R. H., Hansson L., Lacourcière Y., Muller J., Sleight P., Weber M. A., Williams G., Wittes J., Zanchetti A., Anders R. J., Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial. Journal of the American Medical Association 2003 289 16 2073 2082 10.1001/jama.289.16.2073 (Pubitemid 37430209)
13. Morich F. J., Bieber F., Lewis J. M., Kaiser L., Cutler N. R., Escobar J. I., Willmer J., Petersen R. C., Reisberg B., Nimodipine in the treatment of probable Alzheimer's disease: results of two multicentre trials. Clinical Drug Investigation 1996 11 4 185 195 2-s2.0-0030009517
14. Atienza R. C., Extremera B. G., Hipertensión arterial y capacidad intelectual. Hipertensión 2000 17 5 216 224
15. Poole-Wilson P. A., Lubsen J., Kirwan B. A., Van Dalen F. J., Wagener G., Danchin P. N., Just P. H., Fox P. K. A. A., Pocock P. S. J., Clayton T. C., Motro P. M., Parker P. J. D., Bourassa M. G., Dart P. A. M., Hildebrandt P., Hjalmarson P. A., Kragten J. A., Molhoek G. P., Otterstad J. E., Seabra-Gomes R., Soler-Soler P. J., Weber P. S., Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. The Lancet 2004 364 9437 849 857 2-s2.0-4544304433 10.1016/S0140-6736(04)16980-8 (Pubitemid 39221062)